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Mammalian erythropoiesis occurs within erythroblastic islands (EBIs), niches where
maturing erythroblasts interact closely with a central macrophage. While it is generally
accepted that EBI macrophages play an important role in erythropoiesis, thorough
investigation of the mechanisms by which they support erythropoiesis is limited largely
by inability to identify and isolate the specific macrophage sub-population that constitute the EBI. Early studies utilized immunohistochemistry or immunofluorescence
to study EBI morphology and structure, while more recent efforts have used flow
cytometry for high-throughput quantitative characterization of EBIs and their central
macrophages. However, these approaches based on the expectation that EBI macrophages are a homogeneous population (F4/80+/CD169+/VCAM-1+ for example) provide an incomplete picture and potentially overlook critical information about the nature
and biology of the islands and their central macrophages. Here, we present a novel
method for analysis of EBI macrophages from hematopoietic tissues of mice and rats
using multispectral imaging flow cytometry (IFC), which combines the high-throughput
advantage of flow cytometry with the morphological and fluorescence features derived
from microscopy. This method provides both quantitative analysis of EBIs, as well
as structural and morphological details of the central macrophages and associated
cells. Importantly, the images, combined with quantitative software features, can be
used to evaluate co-expression of phenotypic markers which is crucial since some
antigens used to identify macrophages (e.g., F4/80 and CD11b) can be expressed on
non-erythroid cells associated with the islands instead of, or in addition to the central
macrophage itself. We have used this method to analyze native EBIs from different
hematopoietic tissues and evaluated the expression of several markers that have been
previously reported to be expressed on EBI macrophages. We found that VCAM-1,
F4/80, and CD169 are expressed heterogeneously by the central macrophages within
the EBIs, while CD11b, although abundantly expressed by cells within the islands, is not
expressed on the EBI macrophages. Moreover, differences in the phenotype of EBIs in
rats compared to mice point to potential functional differences between these species.
These data demonstrate the usefulness of IFC in analysis and characterization of EBIs
and more importantly in exploring the heterogeneity and plasticity of EBI macrophages.
Keywords: erythropoiesis, erythroblastic islands, macrophages, imaging flow cytometry, CD11b, VCAM-1, CD169,
CD163
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INTRODUCTION

synthesis and growth signals to regulate erythroblast proliferation and differentiation (16, 17), a speculation originally made
by Marcel Bessis in 1960s.
Although these studies have highlighted a functional role for
the central macrophage, the identity of the specific phenotype
of the EBI macrophage remains to be defined. One major
stumbling block in the characterization of these erythropoietic
niches is the lack of specific phenotypic markers to precisely
discriminate an island macrophage from other resident/
stromal macrophages. The F4/80 antigen has historically been
used to identify EBI macrophages in murine tissues; however,
F4/80 is widely expressed on eosinophils, monocytes and
many, although not all, tissue resident macrophages including
liver (Kupffer cells), splenic red pulp but not marginal zone,
adrenal glands, and microglia (18). Additional markers such
as CD169 in the mouse (19), and CD163 in the rat (20), have
been identified using immunofluorescence and flow cytometry
approaches. Due to the close interaction between erythroblasts
and the central macrophage, critical adhesion molecules such as
erythroblast macrophage protein (EMP) and vascular cell adhesion molecule-1 (VCAM-1) have also been implicated as surface
markers of the central macrophage but they are also expressed
on a variety of other cell types (21, 22). Flow cytometry studies
recently highlighted CD11b, a monocyte marker, as a potential
surface marker for the central macrophage in the mouse BM
and SP (23).
In this study, we present a novel method for analysis and
characterization of EBI macrophages from hematopoietic tissues using multispectral imaging flow cytometry (IFC), which
combines the high-throughput advantage of flow cytometry
with the morphology and fluorescence details obtained from
microscopy. Using this method to study EBIs recovered directly
from tissues, we are able to perform in an automated matter nonbiased evaluation of structural and morphological characterization of the central macrophage and surrounding erythroblasts.
Using CD11b, VCAM-1, F4/80, CD163, and CD169 as potential
markers for the central macrophage, and Ter119 or Glycophorin
A and CD71 as markers for erythroblasts, we analyzed these
structures in mouse and rat hematopoietic tissues. While we
confirmed expression of CD169 and VCAM-1 on the F4/80+
central macrophage of EBIs in the mouse, we also identified a
population of VCAM-1+/F4/80− cells associated with erythroblasts in clusters resembling EBIs. CD163 was detected in the
EBI macrophages in rats but not in mice. Most notably, CD11b
was detectable as a membrane marker in other cells present in
EBIs but not in the central macrophage. These findings suggest
that IFC could potentially serve as a comprehensive method for
the analysis and characterization of EBIs and for unraveling the
heterogeneity of EBI macrophages within the same tissue and
between different hematopoietic tissues.

Erythropoiesis is the most demanding aspect of hematopoiesis
in terms of number of cells that need to be produced each day. An
adult human throughout his life span produces approximately
2.5 million red blood cells per second (1) and an adult mouse
7,000 red blood cells per second under steady-state condition.1
During mammalian development, erythropoiesis occurs in three
waves; primitive, fetal definitive, and adult definitive (4). Each of
these waves is regulated both temporally and spatially. After the
primitive wave occurs in the yolk sac, erythropoiesis migrates to
the fetal liver (FL) and finally to the bone marrow (BM) (4). In
the mouse, the BM cannot expand significantly to mount stress
erythropoiesis, in which case the spleen (SP) becomes the major
erythropoietic organ (5).
Erythropoiesis begins with the commitment of a hematopoietic stem cell (HSC) into the megakaryocyte-erythroid lineage
by differentiation to the megakaryocyte-erythroid progenitor.
Within this population, the burst-forming unit-erythroid and
the more mature colony-forming unit-erythroid (CFU-E)
progenitors are exclusively committed to the erythroid lineage
and generate the erythropoietic precursors, which are identified
based on their morphology as proerythroblasts, basophilic,
polychromatophilic, and orthochromatic erythroblasts (6). The
erythroblast phase or terminal erythropoiesis concludes after
four to five cell divisions with the enucleation of the orthochromatic erythroblast which generates a pyrenocyte, containing the
nucleus, and a reticulocyte that further matures into a red blood
cell (7–9).
From the CFU-E to the nascent reticulocyte, differentiating erythroid progenitors and precursors are in close contact
with a central macrophage. Together, they form an anatomical
structure, that was first defined in 1958 as “the functional unit
of the bone marrow” by Marcel Bessis who designated these
structures erythroblastic islands (EBIs) (10). Observed at first
in the rat BM, EBIs have been recognized as niches for erythropoiesis, where positive and negative regulation of terminal
erythroid differentiation is organized and coordinated. They
have been observed in different erythropoietic organs, such
as the FL, the BM and the SP of diverse mammalian species
(11, 12), including human BM (13). The interactions of erythroblasts with the central macrophage and the extracellular matrix
within the island are critical for optimal proliferation, survival,
differentiation, and efficient enucleation (14, 15). Indeed, the
central macrophage is responsible for proper disposal of the pyrenocyte once extruded, and some recent studies demonstrated
that the macrophage can also provide iron for hemoglobin
1
Based on calculations by Palis (1), considering that adult human blood normally
contains approximately 5 × 106 RBCs/µL and the blood volume of a 70 kg person
is approximately 5 L, the total circulating RBCs are 2.5 × 1013. With the lifespan of
human RBCs being approximately 115 days (2), we replace on average 1/115th of
our red cells every day, or 2.2 × 1011 RBC/day, which amounts to 2.5 million RBCs/
sec. Similarly, adult mouse blood normally contains approximately 10 × 106 RBCs/
µL and the blood volume of a 30 g adult mouse is approximately 2.4 mL, which
amounts to 2.4 × 1010 total circulating RBCs. Since the lifespan of mouse RBCs is
approximately 40 days (3) they replace on average 1/40th of their red cells every
day, or 0.6 × 109 RBC/day, which amounts to ~7,000 RBCs/s.

Frontiers in Immunology | www.frontiersin.org

MATERIALS AND METHODS
C57Bl/6 mice 4–6 months of age were used because few EBIs are
recovered from BM of mice less than 2 months of age. SpragueDawley rats used were between 3 and 5 months of age. All mouse
and rat protocols were approved by the Institutional Animal Care
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and Use Committees of Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH, USA, and the Feinstein Institute for
Medical Research, Manhasset, NY, USA.

Cells were harvested from the BM, SP, and FL of a WT mouse,
stained in FACS buffer with FVD780 (eBioscience), F4/80-AF647,
CD169-PE, and VCAM-AF488 (Biolegend), and analyzed on a
FACSCanto flow cytometer (BD). The data were analyzed using
FlowJo (FlowJo LLC, Ashland, OR, USA).

Preparation of EBI Samples from BM

Tibiae and femurs were harvested from C57Bl/6 mice and were
flushed with a 25 G needle attached to a syringe containing
IMDM with 20% FBS, 1 mM CaCl2, and 1 mM MgCl2 (“EBI
buffer”). The BM cells and cell aggregates in suspension were
gently pipetted through a 1 mL pipette to break up large pieces
of tissue, filtered through a 70 µm cell strainer, and then counted
and fixed with 4% PFA for 20 min at room temperature.

Immunofluorescence

Fixed BM EBI suspensions prepared as described above were
cytospun onto a poly-lysine-coated cover glass at 400rpm followed by additional fixation with 4%PFA for 20 min. Coverslips
were washed and then incubated with antibodies overnight at
4°C in PBS + 2% BSA + 2% FBS. After washing, coverslips were
incubated with DAPI in PBS + 0.1% Triton-X-100 for 10 min,
washed and mounted using Fluoromount-G (SouthernBiotech).

Induction of Stress Erythropoiesis

Stress erythropoiesis was induced in C57BL/6 mice by phlebotomy removing 500 µL whole blood followed by fluid replacement intraperitoneally with normal saline. After 4 days, the mice
were euthanized and the SPs were removed and crushed through
a 70 µm filter into EBI buffer; cell count was determined and the
cells were fixed with 4% PFA as above.

Statistics

Statistical analysis was performed using KaleidaGraph software
v.4.1.3 (Synergy Software). Comparison between two groups
with distribution of values that appeared asymmetric indicating
non-normality was performed using the Wilcoxon rank-sum
test that makes no assumptions about the underlying probability distributions. For each set of measurements, we report the
mean and the median for each group and the two-tailed p-value
according to the Wilcoxon rank-sum test. Significance was set
at p < 0.05.

Timed Pregnancies

Mice were paired for 24 h. The following morning, considered
as day E0.5, females were pulled and housed in separate cages.
On embryonic day E13.5, pregnant females were euthanized and
embryos were collected. The FLs were harvested, gently dissociated by pipetting, and filtered through a 70 µm cell strainer; cell
count was determined and the cells were fixed with 4% PFA as
above.

RESULTS
Flow Cytometric Analysis of
Hematopoietic Tissues

IFC

Fixed EBI preparations from BM (BM), SP, or FL were used
within 24 h of preparation. A volume containing 106 single
cells was used from each sample. The cell suspensions were
blocked with anti-FcR (BDBioscience) for 20 min at room temp.
Samples were then centrifuged and re-suspended in FACS buffer
(PBS + 0.5% BSA) containing the applicable fluorescently conjugated antibodies and Hoechst 34580 (Invitrogen). Antibodies
used were anti-F4/80-AF647, anti-CD169-FITC, and PE,
anti-CD106-AF488 (Biolegend); anti-Ter119-FITC, anti-CD71PE and BV421, anti-CD11b-PE, and APC (BDBiosciences);
anti-CD163-PE (R&Dsystems), anti-F4/80-AF488 (Invitrogen),
and anti-CD169-FITC (AbDSerotec). Samples were covered and
incubated on a shaker at 37°C with gentle mixing for 1 h and
then washed twice with FACS buffer and re-suspended in the
same for analysis on the ImageStreamX (EMD Millipore). Data
was collected using a 60× objective and the classifier Area BF
lower limit set to 50. The Similarity feature is the log transformed
Pearson’s Correlation Coefficient and compares two images
within a “masked” region, measuring the degree to which they
are linearly correlated. The Circularity feature measures the
degree that the “mask” of an image deviates from a circle, as
expressed by the average distance of the image boundary from
its center divided by the variation of this distance. The closer the
object to a circle, the smaller the variation, and therefore, the
feature value will be high.

Frontiers in Immunology | www.frontiersin.org

Erythroblastic island macrophages have been most well characterized in BM of mammals (24) while the macrophages in
EBIs in FL or in the mouse SP after induction of stress erythropoiesis have received less attention. When we compared these
hematopoietic tissues in mice by flow cytometry, we found a
variable expression of the known BM EBI macrophage markers:
the classic murine macrophage marker F4/80, the sialoadhesin
CD169, and VCAM-1 (Figure 1A). The BM contains up to
10% of cells that are double positive for F4/80 and CD169 and,
also, demonstrate a high level of VCAM-1 expression. FL and
stressed SP show relatively low CD169 expression; nevertheless,
the F4/80+;CD169+ cells, as well as the F4/80+/CD169− cells,
still express VCAM-1 at high levels. Of note, this low expression of CD169 in the FL F4/80+ cells is in agreement to a study
published by Siamon Gordon’s team in 1991 where sialoadhesin
was not detected in FL macrophages in contrast to stromal
macrophages in adult BM (19). F4/80 and CD169 expressions
in splenocytes were not significantly affected by induction of
stress erythropoiesis (Figure 1B). This data indicates a variable
degree of expression of the known EBI macrophage markers
between hematopoietic tissues and even within the same tissue.
Therefore, to address the heterogeneity of this population, we
sought an unbiased assay for phenotypic characterization of
the EBI macrophages based on their defining characteristic:
participating in EBI formation.
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A

B

Figure 1 | Flow cytometric analysis of F4/80, CD169, and vascular cell adhesion molecule-1 (VCAM-1) expression levels within the bone marrow (BM), fetal liver
(FL), and spleen (SP) of C57Bl/6 mice. (A) The BM contains the largest double positive for F4/80 and CD169 population and demonstrates a high level of VCAM-1
expression. VCAM-1 expression is plotted in the lower graphs in red (Q1: F4/80−;CD169+), light blue (Q2: F4/80+;CD169+), orange (Q3: F4/80+;CD169−), or green
(Q2: F4/80−;CD169−). Although the FL and stressed SP have lower amounts of F4/80+;CD169+, these double positive cells at the Q2 quadrant still express VCAM-1
highly. (B) Expression of CD169 and F4/80 in the spleen does not change significantly after induction of stress erythropoiesis.

Frontiers in Immunology | www.frontiersin.org

4

September 2017 | Volume 8 | Article 1140

Seu et al.

Unravelling Macrophage Heterogeneity in EBIs

Analyzing Intact EBIs with IFC

Assessment of EBI Macrophages by IFC

Intact EBIs were obtained by flushing BM with media containing
divalent ions to preserve integrin-mediated intercellular inter
actions, followed immediately by fixation, preserving the
structure of the native islands prior to staining and analysis on
the ImageStreamX. In the analysis software, larger cell clusters
are first gated on the basis of their area in the brightfield channel
and then evaluated for expression of the erythroid marker CD71
and macrophage marker F4/80 (Figure 2A). The population
within the double positive gate (EBI gate) is markedly enriched
in EBIs, characterized by the presence of a central F4/80+ macrophage surrounded by several (for the purposes of this study,
3 or more) CD71+ erythroblasts (Figure 2B). Consistent with
previous descriptions of EBIs, the participating cells often overlap
considerably, indicating likely multiple intercellular interactions;
extensions from the macrophage can also be seen between the
associated erythroblasts. Of note, examination of the events
within this population by direct observation of each cluster on
IFC is necessary since the CD71+/F4/80+ double positive gate
does not contain solely EBIs, but is “contaminated” with loose
and/or non-specific cell clusters that do not fit the criteria of an
EBI (Figure 2C). “Blind” flow cytometry could not exclude such
events, potentially leading to misguided conclusions about EBI
macrophage markers. True EBIs (containing a central F4/80+ macrophage and at least three CD71+ erythroblasts) comprised as low
as 20–50% of the CD71+/F4/80+ double positive population. This
percentage is in agreement with previous calculations by Crocker
and Gordon, who concluded, after enrichment of mouse BM cell
clusters by gravity sedimentation, that only ~7% of BM cells
were in clusters, and only 40% of those contained erythroblasts
(23). These observations underscore the advantage of IFC versus
regular flow cytometry for evaluation of EBI characteristics.
The same analysis was performed with SPs from mice that had
been phlebotomized to induce stress erythropoiesis (Figure 2D),
as well as with mouse FL s. In FL s, EBIs with a central F4/80+ macrophage were identified with decreased frequency. Examination
of the cell clusters outside of the F4/80+/CD71+ gate showed many
island-like structures of CD71+ cells that lacked F4/80 positivity. Of the F4/80+ EBIs, one notable difference was the shape of
the macrophages in FL s. While macrophages in the BM EBIs
(and stressed SP EBIs) had typically an irregular appearance
with many elongated extensions reaching throughout the cell
cluster, in contrast, FL EBIs often had rather round, perhaps less
mature, macrophages serving as the nurse-cell for erythroblasts
(Figure 2E). Using the analysis software, this qualitative finding
could be quantitated by the circularity feature which measures
how much a staining pattern deviates from a circle. It is calculated
by dividing the average distance of the stain boundary to the
center by the variation of this distance. The closer an object is to
a circle, the smaller the variation and thus the higher the value
of the circularity feature. The median value for circularity of the
FL EBI macrophages at 8.78 was significantly higher than that
of the BM macrophages at 3.61, confirming the initial impression that the FL macrophages are relatively round (p < 0.0001).
Macrophages from stressed SPs were similar in shape to the BM
macrophages (median of 3.3).

Frontiers in Immunology | www.frontiersin.org

With a method of collecting and analyzing EBIs and their central
macrophages established, we set out to validate a number of cell
surface receptors that have been previously relied upon to identify
the EBI macrophages.

CD11b

Jacobsen et al recently used CD11b among other markers to
identify EBI macrophages by flow cytometry (25). However, our
analysis using IFC showed that CD11b is not detected on the
F4/80 + central macrophages; it is rather a marker of other cells
participating in the EBI formation (Figure 3A). This finding is
in agreement to a previous report by Crocker and Gordon which
demonstrated the central macrophages of EBIs to be negative
for Mac-1/CD11b (23). Of interest, the majority (up to 80%) of
EBIs analyzed (520 EBIs total from 4 independent experiments
with BM samples) contained at least one or more CD11b+ cells
associated with the island, likely monocytes and neutrophils as
observed by Crocker and Gordon (23). We confirmed our IFC
findings with immunofluorescence microscopy of fixed BM
clusters (Figures 3B,C). The ratio of EBs to CD11b+ cells at the
islands varied, ranging from islands with only one CD11b+ cell
among the EBs to clusters in which the CD11b+ cells equaled or
outnumbered the EBs (Figure 3D). EBIs from FLs and stressed
SPs, on the other hand, contained very few, if any, CD11b+ cells
despite the presence of CD11b+ single cells in both the SP and FL
(data not shown).

VCAM-1

As expected, VCAM-1, the complementary receptor for erythroblast integrin α4β1, was expressed on every F4/80+ EBI
central macrophage in all three murine hematopoietic tissues
(Figures 4A,B). A surprising finding was that there were
several clusters resembling EBIs in brightfield, where CD71+
cells surrounded a central VCAM-1+ cell that, however, lacked
appreciable F4/80 staining. The presence of these clusters varied
in the BM samples between 5 and 20% of CD71+ clusters, while
it increased in the BM and SPs of mice induced to develop
stress erythropoiesis to up to 30–40% of total CD71+ clusters
(Figure 4C). In addition, the presence of these F4/80− clusters
was quite prominent in the FL samples (between 50 and 75% of
total CD71+ clusters) (Figure 4C). These clusters likely account
for the many island-like structures of CD71+ cells in the FL
specimens, which we observed that lack F4/80 positivity, as
noted above.

CD169

CD169+ macrophages in the bone marrow have been shown to
promote retention of HSCs and erythroid progenitors (26, 27)
and are presumed to be involved in EBIs. We tested a number
of CD169 antibodies (3D6.112, REA197, and MOMA-1), which
performed as reported in traditional flow cytometry (Figure 1),
but gave inconsistent results in IFC and immunofluorescence
microscopy. The best performing anti-CD169 for IFC and immunofluorescence was the REA197 clone (Miltenyi Biotec Inc.), but
this also gave strong staining of the FL macrophages which are
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A

B

C

D

E

Figure 2 | Gating strategy of erythroblastic islands (EBIs) for analysis by imaging flow cytometry (IFC). (A) Left panel: multiplets (cell clusters) characterized by their
large area in brightfield (BF) are gated. Right panel: the cell clusters are then plotted as per intensity of F4/80 and of CD71 stain. The gate containing clusters high in
fluorescence intensity for both F4/80 and CD71 is enriched in EBIs (gate). Manual inspection of the cell clusters in the EBI gate allows confirmation of the events (tagged
yellow) that clearly have the structure of an EBI. Some EBIs are located outside of the EBI gate but with decreased frequency. (B) Examples of EBIs (representative of
the yellow-marked events within the EBI gate) characterized by a central F4/80+ macrophage surrounded by CD71+ and/or Ter119+ erythroblasts. An anucleate
reticulocyte (arrow) is occasionally seen, still in contact with the macrophage. (C) Examples of cell clusters, which although within the EBI gate (double positive for F4/80
and CD71), do not have the classic appearance of an intact EBI. These events would have been included in the analysis by “blind” flow cytometry, potentially leading to
misguided conclusions about EBI macrophage markers. (D) Representative examples of EBIs isolated from mouse spleen after development of stress erythropoiesis
(4 days post-induction of anemia with phlebotomy of 500 µL of blood). (E) Representative examples of EBIs isolated from mouse fetal livers (E13.5).
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A

B

C

D

Figure 3 | The central macrophage in erythroblastic islands (EBIs) is not CD11b+; however, other CD11b+ cells may participate in the EBI structure. (A) Mouse
bone marrow EBIs stained with fluorescently conjugated antibodies against CD71, CD11b, and F4/80 and analyzed by imaging flow cytometry (IFC) indicate that
CD11b positivity in EBIs is due to CD11b+ cells peripherally attached to the EBI macrophage and/or the erythroblasts; the central macrophage is not CD11b+.
(B) A representative EBI imaged by immunofluorescence microscopy also showing that the F4/80+ central macrophage is not stained by anti-CD11b, while a cell
attached to the macrophage and another one in close proximity are CD11b+. (C) Another example showing that F4/80+ cells in mouse bone clusters are not
CD11b-bright, in contrast to adjacent cells that have a clear membranous stain for CD11b. (D) IFC analysis of mouse bone marrow EBIs, stained for F4/80, CD71,
and CD11b indicates that CD11b+ cells are a consistent component of the EBI.

reported to lack CD169 (19, 28) so we restricted our analysis to
the widely used (at least for flow cytometry) 3D6.112 clone.
Though some EBI macrophages with clear CD169 staining were
observed, many had little or no CD169 detectable (Figure 5A).
Moreover, when CD169 was detectable on the EBI macrophages,
the pattern was irregular rather than continuous membranous
staining and, therefore, difficult to compare with the F4/80 signal. In order to compare the intermittent CD169 staining with
the F4/80 expression on the central macrophage, a threshold

Frontiers in Immunology | www.frontiersin.org

mean pixel intensity was set to determine CD169 positivity and
the similarity feature, a modification of Pearson’s correlation
coefficient, was used to objectively determine if the CD169
staining was consistent with the F4/80. At least 90% of F4/80+
EBI macrophages were positive by this measure and the mean
similarity score indicated that the staining, although heterogeneous, is more similar to F4/80 than not. For reference, this can be
compared to the high similarity of VCAM-1 to F4/80, in contrast
to CD11b and F4/80, which are not co-expressed (Figure 5B).
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A

B

C

Figure 4 | Central macrophages are VCAM-1+. (A) All of the erythroblastic island (EBI) macrophages in the mouse bone marrow are positive for vascular cell
adhesion molecule-1 (VCAM-1) (top), while there are a few additional clusters of erythroblasts surrounding VCAM-1+;F4/80lo macrophages (bottom). (B) Similarly, in
the mouse fetal liver EBIs, all F4/80+ central macrophages are also VCAM-1+ (top). However, the clusters containing CD71+ erythroblasts around a central VCAM-1+
cell with low or intermediate F4/80 staining in the fetal liver are much more frequent than in the bone marrow (bottom). (C) CD71+ clusters with VCAM-1+;F4/80lo
macrophages are significantly increased in the fetal liver (74 ± 6%) compared to steady-state bone marrow (10 ± 2%). A smaller but significant increase is seen in
the spleen (30 ± 2%) and bone marrow (39 ± 8%) after induction of stress. Data shown are mean ± SE, *p ≤ 0.05, **p ≤ 0.001.

(Figure 6A), we could also identify clusters without the classic
appearance of an island (Figure 6D) that had to be manually
excluded for further analysis. CD163 has been identified as a
membrane protein on rat and human BM macrophages and has
been shown to function as an adhesion receptor for erythroblasts
as well as a scavenger for hemoglobin–haptoglobin (Hb–Hp)
complexes, contributing to the clearance of free hemoglobin
(20). Interestingly, CD163 was not significantly detectable on

CD163 in Rat BM EBI Macrophages

Erythroblastic islands were originally described in rat BM.
We tested our method and IFC analysis strategy to prepare
and visualize EBIs from BM isolated from Sprague-Dawley
rats (Figure 6A). The central macrophage was consistently
positive for CD163; CD169 was not detectable with clone ED3
(Figures 6B,C). Although the EBIs were enriched (20–44%) in
the cell clusters within the CD71/CD163 double positive gate

Frontiers in Immunology | www.frontiersin.org
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A

B

Figure 5 | The majority of mouse bone marrow erythroblastic island (EBI) macrophages are CD169 + although the staining pattern is heterogeneous.
(A) By imaging flow cytometry, some F4/80+ EBI macrophages appear CD169+ (top), but many do not exhibit clear staining (bottom). Staining was suboptimal with
all anti-mouse CD169 antibodies tested and positivity was determined by mean pixel value since a clear image was not always observed. (B) The similarity feature
was used to compare the staining pattern of the CD169 to that of F4/80. The mean value for the similarity of CD169 to F4/80 was 1.7 ± 0.2 (242 EBIs from four
biological samples), whereas vascular cell adhesion molecule-1 (VCAM-1), which had a high correlation with F4/80 expression, has mean value of 2.2 ± 0.6 (811
EBIs, 10 biological samples) and CD11b, which was very dissimilar from F4/80, gives a mean value of 0.82 ± 0.4 (484 EBIs, 6 biological samples). Distributions
shown are from representative experiments.

murine BM EBI macrophages (Figure 7A), while it was easily
detected by IFC on other cells present in the same BM preparation (Figure 7B) as well as by flow cytometry in a population of
peripheral blood cells, indicating that the antibody does react
with murine cells as well as it does with human monocytes
(Figure 7C).

from integral participation in the immune defenses to their
trophic role as stromal cells, supporting tissue homeostasis and
regeneration (29). They even have variable origin with some
of the tissue resident macrophages, including the resident BM
macrophages (RBMMs), originating from the erythro-myeloid
progenitors of the yolk sac and not from the HSC-derived
myelo-monocytic lineage (30, 31). The RBMMs in the BM
spread cellular processes to create an extended meshwork forming clusters with myeloid and erythroid cells (23). The clusters
composed of erythroblasts surrounding a central macrophage
were first observed almost 60 years ago as EBIs and have been

DISCUSSION
Macrophages are a heterogeneous population with wide distribution in different tissues and variable functions that range
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A

B

C

D

Figure 6 | Analysis of erythroblastic islands (EBIs) from rat bone marrow by IFC. (A) Left panel: Multiplets (cell clusters) characterized by their large area in brightfield
(BF) are gated. Right panel: The cell clusters are then plotted as per intensity of CD163 and of CD71 stain. The gate containing clusters high in fluorescence intensity
for both CD163 and CD71 is enriched in EBIs (EBI gate). Manual inspection of the cell clusters in the EBI gate allows confirmation of the events that have clearly the
structure of an EBI. (B,C) Examples of EBIs (within the EBI gate) characterized by a central CD163+/CD169− macrophage surrounded by CD71+ erythroblasts.
(D) Examples of cell clusters which although within the EBI gate (double positive for CD163 and CD71) do not have the classic appearance of an intact EBI. These
events would have been included in the analysis by “blind” flow cytometry, potentially leading to misguided conclusions about EBI macrophage markers.

proven over the years to be the erythropoietic niches, optimizing erythroblast proliferation, differentiation, survival, and
enucleation (10, 14, 15).
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We have evaluated here cell surface markers that have been
used to define and study the murine EBI macrophages (25, 26, 32).
The interactions of erythroblasts with the EBI macrophages had
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A

B

C

Figure 7 | CD163 is poorly detectable in mouse erythroblastic island (EBI) macrophages by imaging flow cytometry. (A) Antibodies against CD163 did not reliably
stain the mouse EBI macrophages. (B) There were cells at the same experiment, single or present in clusters, which were stained as CD163+. (C) Flow cytometric
analysis of unfixed murine peripheral WBCs showed that the antibody used labels mouse peripheral blood cells as well as it labels human monocytes.

been described early on as either divalent cation dependent,
mediated by a putative erythroblast receptor (EbR), or cationindependent (33). The cation-independent receptor was identified on RBMMs as a lectin-like agglutinin that could avidly bind
non-opsonized sheep erythrocytes, and therefore, it was named
initially SER (sheep erythrocyte receptor) (34). SER is now
known as CD169, and it has been shown to be present in certain
sub-populations of stromal tissue macrophages, especially those
in lymph nodes, BM, liver, and SP, while it is low or undetectable on blood and BM monocytes and on macrophages isolated
from thymus, peritoneal or pleural cavity, and bronchoalveolar
spaces (34, 35). The divalent cation-dependent EbR was shown
to be the dominant erythroblast adhesion receptor(s) on mouse
bone marrow stromal macrophages (19) and was soon identified as the VCAM- (22) binding to α4β1 integrin on erythroblast
membrane (36). The αv integrin was also identified as a stromal
macrophage receptor binding the erythroblast ICAM-4 and
contributing an additional cation-dependent, integrin-mediated
adhesive interaction (37).
None of these EBI macrophage markers is specific enough
to be used as a single defining characteristic of this macrophage
Frontiers in Immunology | www.frontiersin.org

sub-population. Combinations of F4/80, VCAM-1, CD169,
and CD11b have been considered a more reliable alternative
(25, 26, 32). We used IFC to evaluate EBIs isolated from murine
BM, stress-erythropoietic SP, and FL. IFC gives the advantage
of high-throughput data analysis combined with the visualization of immunofluorescent staining for each event. With this
technique, we were able to examine the phenotype and characteristics of EBIs and their central macrophages and identify
morphological and immunophenotypic differences between different hematopoietic tissues in the mouse. We were also able to
evaluate EBIs from rat BM, opening the possibility to investigate
similarities and differences between species (24).
Our data demonstrated a variable degree of expression of
F4/80, VCAM-1, and CD169, in the EBI macrophages between
hematopoietic tissues and even within the same tissue, indicating
that these markers are not only non-specific, but they also show a
significant heterogeneity within this macrophage sub-population.
A total of 5–20% of morphologically defined EBIs in the murine
BM had a central macrophage without appreciable F4/80 positivity, in agreement with Crocker and Gordon who observed strong
F4/80 staining in only 70% of the clusters they analyzed from
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murine BM (23). We found these F4/80− central macrophages to
express VCAM-1. The EBIs with F4/80−;VCAM-1+ macrophages
were significantly increased in conditions of stress erythropoiesis:
in BM and SP of anemic mice after phlebotomy, as well as in
FLs, where erythropoiesis needs to meet the exceptionally fast
rate of growth in embryonic life. This variation in the cell surface
markers of EBI macrophages likely signifies a deeper biological
difference between the erythropoietic niches under homeostatic
and stress erythropoiesis. Along with distinct erythroid progenitors and cytokine signaling pathways (5), stress erythropoiesis
may also utilize nurse macrophages of different origin and with
special characteristics.
We also found wide heterogeneity of CD169 staining on the
BM EBI macrophages by IFC. CD169 is a sialoadhesin that acts
as a receptor for sialylated glycoconjugates and plays multiple
and discrete roles in the hematopoietic, immune, and nervous
systems, via adhesive and signaling interactions (38). A significant heterogeneity of CD169 distribution on the RBMMs was also
demonstrated in the past, when this marker was first identified as
SER (34). Crocker and Gordon showed by immunofluorescence
and immunoelectron microscopy in mouse BM that SER is faintly
stained at the border between macrophage and erythroblasts,
whereas it is highly concentrated at the contact zones between
macrophages and immature granulocytes and eosinophils (39).
Of note, the same team demonstrated that binding of erythro
blasts to FL macrophages is completely resistant to specific
monoclonal antibody inhibitors of sialoadhesin and CD169 is not
detectable on FL macrophages (19, 28). Thus, our difficulty imaging this receptor consistently in the EBI macrophages is likely due
to its truly variable expression in this macrophage sub-population
rather than to technical issues with anti-CD169 antibodies. This
heterogeneity may also reflect heterogeneity in function of the
corresponding EBI macrophages in erythropoiesis.
Most notable is our finding that the central macrophages
in murine EBIs lack appreciable CD11b (Mac-1) expression in
agreement with early studies in human and mouse BM stromal
macrophages (13, 23). Therefore, this antigen is not an optimal
marker to isolate or study EBI macrophages. Given that our studies by IFC showed the majority of BM EBIs to have associated
CD11b+ cells, the CD71+;F4/80+ clusters would appear CD11b+
in a flow cytometer; therefore, use of this marker in a blind gating
strategy may still yield a population of EBIs (25). However, our
data show that CD11b is not on the F4/80+ macrophages themselves but on non-erythroid, non-macrophage cells associated
with the islands. This finding is consistent with previous descriptions of BM cell clusters. Crocker and Gordon reported that 30%
of BM clusters contained both erythroid and myeloid cells and
immature myeloids were enriched as much as erythroid cells
when clusters were purified by sedimentation (23). Moreover,
CD169 is a receptor for granulocytes and eosinophils and is most
highly concentrated at the contact zones between macrophages
and these cells (39). It is intriguing to consider that myeloid cells
may affect erythropoiesis via direct intercellular interactions
within the erythropoietic niche, but further studies, including
transcriptomics and IFC evaluation for other membrane markers
of the granulocytic lineage, are needed in order to determine the
identity and biological significance of these associated cells and
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their contribution(s) to the function and microenvironment of
the EBIs.
We were also able to image EBIs from the rat BM. The central
macrophage in these EBIs is characterized by the presence of
CD163, a heme scavenger, which is however absent in mouse EBI
macrophages, possibly implying a difference between species in
erythropoiesis regulation. EBIs were first identified in the rat (10).
Most of the studies in the field of erythropoiesis have used so far
in vitro models of human stem and progenitor cells induced to differentiation toward red blood cells or in vivo mouse models because
most of the techniques and reagents (e.g., knockout/knockdown
technologies, antibodies) were restricted until recently to these
animals. However, rat erythropoiesis is a more faithful model of
human erythropoiesis, since unlike the mouse, stress erythropoiesis in the rat occurs mostly in the BM, similar to humans. With
the recent development of CRISPR-Cas9, one may envision the rat
as potential model for normal and disordered erythropoiesis (40).
Imaging flow cytometry has allowed us a better understanding
of morphologic and phenotypic characteristics of the EBIs and
their constituent cells and a clear demonstration of the heterogeneity of the EBI macrophage sub-population, which is not surprising based on the diversity and plasticity of the macrophages in
general. Single-cell RNA-seq of macrophages isolated from EBIs
may be better suited to clarify their heterogeneity and identify
common intercellular interactions and signaling pathways assisting erythropoiesis as well as differences that may play a role in
conditions of stress or pathologic erythropoiesis.
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